This study will evaluate whether the addition of daily BKM120 to weekly paclitaxel is
effective and safe in treating patients with HER2- locally advanced or metastatic breast
cancer.
Minimum age: 18 Years.
Maximum age: N/A.
Gender(s): Female.
Novartis Investigative Site, Salzburg 5020, Austria
Novartis Investigative Site, Vienna A-1090, Austria
Novartis Investigative Site, Charleroi 6000, Belgium
Novartis Investigative Site, Liege 4000, Belgium
Novartis Investigative Site, Liège 4000, Belgium
Novartis Investigative Site, Ottignies 1340, Belgium
Novartis Investigative Site, Sint-Niklaas 9100, Belgium
Novartis Investigative Site, Wilrijk 2610, Belgium
Novartis Investigative Site, Brno 656 53, Czech Republic
Novartis Investigative Site, Olomouc 775 20, Czech Republic
Novartis Investigative Site, Praha 2 128 08, Czech Republic
Novartis Investigative Site, Angers Cedex 9 49933, France
Novartis Investigative Site, Bordeaux 33076, France
Novartis Investigative Site, Creteil 94010, France
Novartis Investigative Site, La Roche sur Yon cedex 9 85925, France
Novartis Investigative Site, Le Mans Cedex 72015, France
Novartis Investigative Site, Marseille 13273, France
Novartis Investigative Site, Nice Cedex 2 06189, France
Novartis Investigative Site, Saint Herblain cedex 44805, France
Novartis Investigative Site, Toulouse Cedex 9 31059, France
Novartis Investigative Site, Villejuif Cedex 94805, France
Novartis Investigative Site, Bonn 53111, Germany
Novartis Investigative Site, Dresden 01307, Germany
Novartis Investigative Site, Erlangen 91054, Germany
Novartis Investigative Site, Frankfurt 60389, Germany
Novartis Investigative Site, Fulda 36043, Germany
Novartis Investigative Site, Mainz 55131, Germany
Novartis Investigative Site, Muenchen 80637, Germany
Novartis Investigative Site, Ravensburg 88214, Germany
Novartis Investigative Site, Ulm 89081, Germany
Novartis Investigative Site, Hong Kong SAR, Hong Kong
Novartis Investigative Site, Budapest 1134, Hungary
Novartis Investigative Site, Debrecen 4032, Hungary
Novartis Investigative Site, Szolnok H-5000, Hungary
Novartis Investigative Site, Ramat Gan 52621, Israel
Novartis Investigative Site, Tel-Aviv 64239, Israel
Novartis Investigative Site, Osaka 537-8511, Japan
Novartis Investigative Site, Osaka 540-0006, Japan
Novartis Investigative Site, Seoul 738-736, Korea, Republic of
Novartis Investigative Site, Breda 4819 EV, Netherlands
Novartis Investigative Site, Rotterdam 3075 EA, Netherlands
Novartis Investigative Site, St. Petersburg 197758, Russian Federation
Novartis Investigative Site, Singapore 119228, Singapore
Novartis Investigative Site, Johannesburg 2196, South Africa
Novartis Investigative Site, Madrid 28034, Spain
Novartis Investigative Site, Madrid 28033, Spain
Novartis Investigative Site, Madrid 28040, Spain
Novartis Investigative Site, Madrid 28009, Spain
Novartis Investigative Site, Zaragoza 50009, Spain
Novartis Investigative Site, New Taipei City 23561, Taiwan
Novartis Investigative Site, Taipei 10048, Taiwan
Novartis Investigative Site, Glasgow - Scotland G12 OYN, United Kingdom
Novartis Investigative Site, London, United Kingdom
Novartis Investigative Site, Nottingham NG5 1PB, United Kingdom
Novartis Investigative Site, Rhyl LL18 5UJ, United Kingdom
Novartis Investigative Site, Wirral CH63 3JY, United Kingdom
Novartis Investigative Site, Nagoya-city, Aichi 467-8602, Japan
Novartis Investigative Site, Nagoya, Aichi 464-8681, Japan
Novartis Investigative Site, Cordoba, Andalucia 14004, Spain
Novartis Investigative Site, Malaga, Andalucia 29010, Spain
Novartis Investigative Site, Sevilla, Andalucia 41013, Spain
Ironwood Cancer and Research Centers SC, Chandler, Arizona 85224, United States
Arizona Oncology Associates Dept of Oncology, Phoenix, Arizona, United States
Highlands Oncology Group Dept of Highlands Oncology Grp, Fayetteville, Arkansas 72703, United States
Novartis Investigative Site, Fortaleza, CE 60336-045, Brazil
California Cancer Care Marian Speciality, Greenbrae, California 94904, United States
Novartis Investigative Site, Barcelona, Catalunya 08003, Spain
Novartis Investigative Site, Barcelona, Catalunya 08036, Spain
Novartis Investigative Site, Hospitalet de LLobregat, Catalunya 08907, Spain
Rocky Mountain Cancer Centers RMCC Hale Pkwy, Greenwood Village, Colorado, United States
Novartis Investigative Site, Valencia, Comunidad Valenciana 46010, Spain
Novartis Investigative Site, Valencia, Comunidad Valenciana 46009, Spain
Novartis Investigative Site, Cona, FE 44100, Italy
H. Lee Moffitt Cancer Center & Research Institute SC, Tampa, Florida 33612, United States
Novartis Investigative Site, Genova, GE 16132, Italy
Novartis Investigative Site, A Coruna, Galicia 15009, Spain
Emory University School of Medicine/Winship Cancer Institute Dept.of WinshipCancerInst. (2), Atlanta, Georgia 30322, United States
Northwest Georgia Oncology Center NW Georgia Onc, Marietta, Georgia 30060, United States
Novartis Investigative Site, Sapporo, Hokkaido 135-8550, Japan
Novartis Investigative Site, Isehara-city, Kanagawa 259-1193, Japan
Novartis Investigative Site, Kawasaki-city, Kanagawa 216-8511, Japan
Novartis Investigative Site, Yokohama, Kanagawa 241-8515, Japan
University of Kansas Cancer Center Univ Kansas 2, Kansas City, Kansas 66160, United States
Novartis Investigative Site, Maidstone, Kent M16 9QQ, United Kingdom
Norton Healthcare, Inc., Louisville, Kentucky 40202, United States
Novartis Investigative Site, Seoul, Korea 110 744, Korea, Republic of
Novartis Investigative Site, Seoul, Korea 135-710, Korea, Republic of
Novartis Investigative Site, Kumamoto City, Kumamoto 860-8556, Japan
Novartis Investigative Site, La Laguna, Las Palmas de Gran Canaria 38320, Spain
Novartis Investigative Site, Monza, MB 20900, Italy
Novartis Investigative Site, Messina, ME 98158, Italy
Novartis Investigative Site, Milano, MI 20141, Italy
Washington University School of Medicine Regulatory, St. Louis, Missouri 63110, United States
University of Nebraska Medical Center Unv Nebraska Med Ctr (2), Omaha, Nebraska 68198, United States
University of New Mexico Cancer Research Center Dept of Univ New Mexico, Albuquerque, New Mexico 87131, United States
Novartis Investigative Site, Sydney, New South Wales 2060, Australia
New York Oncology Hematology, P.C. Dept. of New York Oncology. PC, Troy, New York 12180, United States
Ohio State Comprehensive Cancer Center/James Cancer Hospital SC-1, Columbus, Ohio 43210, United States
University of Oklahoma Health Sciences Center OUHSC 2, Oklahoma City, Oklahoma 73104, United States
Northwest Cancer Specialists Vancouver Loc, Portland, Oregon 97210, United States
Novartis Investigative Site, Suita-city, Osaka 565-0871, Japan
Novartis Investigative Site, Montreal, Quebec H3A 1A1, Canada
Novartis Investigative Site, St.- Petersburg, Russia 197022, Russian Federation
Novartis Investigative Site, São Paulo, SP 01221-020, Brazil
Novartis Investigative Site, São Paulo, SP 01246-000, Brazil
Novartis Investigative Site, São Paulo, SP 01317-904, Brazil
Novartis Investigative Site, Kuei-Shan Chiang, Taoyuan/ Taiwan ROC 33305, Taiwan
Baylor Health Care System/Sammons Cancer Center Baylor Texas Oncology, Dallas, Texas 75246, United States
University of Texas Southwestern Medical Center Harry Hines, Dallas, Texas 75390-8527, United States
Cancer Care Centers of South Texas / HOAST CCC of So. TX- San Antonio, San Antonio, Texas 78229, United States
Novartis Investigative Site, Koto, Tokyo 135-8550, Japan
Novartis Investigative Site, Geelong, Victoria 3220, Australia
Novartis Investigative Site, Parkville, Victoria 3050, Australia
Medical Oncology & Hematology Associates of Northern VA Med Onc Hem Northern VA, Reston, Virginia 20190, United States
Novartis Investigative Site, Perth, Western Australia 6005, Australia